https://www.selleckchem.com/pr....oducts/LY315920(Vare
Katona and non-treated early groups were classified in the same MRI cluster which is the expected for PBD population patients. However, in MEPs and neuropediatric evaluations clustering, the 67% of Katona group were assigned into Healthy group showing the impact of Katona therapy over the patients treated with it. These results highlight the Katona therapy benefits in early rehabilitation of infants with moderate-to-severe PBD. Katona therapy and early rehabilitation have an important therapeutic effect in infants with mod
Like
Comment
Share
